Ritalin suit dismissed with sanctions. The judge also ordered the plaintiffs to pay the defendants' legal fees. The case was dismissed with prejudice, which prohibits it from being refiled. Last month, the judge said that he would dismiss the suit unless the plaintiffs allege and can demonstrate that they have been victimized by any conduct or damage. Rather than attempting to correct their complaint, the plaintiffs announced their intent to appeal the judge's verdict.
Similar suits are pending in New Jersey and Texas.
The principal marketers of Snorenz, a throat spray claimed to eliminate snoring, have settled FTC charges that they lacked adequate substantiation for their claims. The agreements forbid the parties from making unsubstantiated claims that Snorenz or any other food, drug, or dietary supplement reduces or eliminates snoring or eliminates, reduces, or mitigates the symptoms of sleep apnea. Snorenz is a throat spray consisting of oils and vitamins. The product claims also appeared on its labels, on Med Gen's website, and on many other Web sites. This page was posted on May 7, 2001.